Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 4,496 | 4,160 | 3,603 | 4,839 | 5,112 |
| Cost of Goods | 869 | 769 | 684 | 954 | 1,889 |
| Gross Profit | 3,627 | 3,391 | 2,919 | 3,885 | 3,223 |
| Operating Expenses | 6,936 | 5,549 | 6,447 | 8,219 | 7,664 |
| Operating Income | -2,440 | -1,389 | -2,844 | -3,380 | -3,552 |
| Other Income | 67 | 2,748 | -1,965 | 1,266 | 69,568 |
| Pre-tax Income | -2,373 | 1,359 | -4,809 | -2,114 | 66,016 |
| Income Tax | -8 | 8 | N/A | 0 | 11 |
| Net Income Continuous | -2,365 | 1,351 | -4,809 | -2,114 | 66,005 |
| Net Income | $-2,365 | $1,351 | $-4,809 | $-2,114 | $66,005 |
| EPS Basic Total Ops | -0.02 | 0.02 | -0.16 | 2.30 | 15.34 |
| EPS Basic Continuous Ops | -0.02 | 0.02 | -0.15 | 2.68 | 15.58 |
| EPS Diluted Total Ops | -0.02 | 0.00 | -0.16 | 7.23 | 0.10 |
| EPS Diluted Continuous Ops | -0.02 | 0.00 | -0.15 | 7.24 | 0.09 |
| EPS Diluted Before Non-Recurring Items | -0.02 | 0.00 | -0.16 | N/A | N/A |
| EBITDA(a) | $-2,146 | $-1,347 | $-2,785 | $-4,617 | $-3,464 |